Rome V: refining the language of gut–brain disorders The Lancet Gastroenterology & Hepatology ++... ++

Rome V: refining the language of gut–brain disorders The Lancet Gastroenterology & Hepatology https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00157-3/fulltext?dgcid=raven_jbs_etoc_email Jul 2026 Volume 11Number 7p541-644, e9 https://www.thelancet.com/journals/langas/issue/vol11no7/PIIS2468-1253(26)X2005-2 The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729–001): a phase 1a/b trial Prof Man-Fung Yuen, MD, DSca Send email to mfyuen@hku.hk ∙ Prof Edward Gane, MDb,c ∙ Jacinta A Holmes, PhDd ∙ Prof Simone I Strasser, MDe ∙ Apinya Leerapun, MDf ∙ Wattana Sukeepaisarnjaroen, MDg ∙ et al. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00058-0/abstract?dgcid=raven_jbs_etoc_feature_langas Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial Laura R Moolenaar, MDa,b ∙ Mahsoem Ali, BSca,b ∙ Theo J Aufenacker, MD PhDc ∙ Prof Geerard L Beets, MD PhDd,e ∙ Robbert J I Bosker, MD PhDf ∙ Tineke E Buffart, MD PhDb,g ∙ et al. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00109-3/abstract?dgcid=raven_jbs_etoc_feature_langas